Brachytherapy for advanced prostate cancer bleeding.
Advanced prostate cancer patients frequently deal with intractable prostatic bleeding which is a difficult problem to manage. Intraurethral high-dose rate (HDR) brachytherapy may palliate this condition. Advanced prostate cancer patients with intractable prostatic bleeding were offered brachytherapy with Iridium-192 using a Micro-selectron HDR machine. During a 5-year period, analysis was performed in 23 patients with a median age and Gleason score of 78 years and 9, respectively. Following brachytherapy, haematuria resolved in 19 of the 23 patients and was recurrence free at 6 months. Intraurethral HDR brachytherapy is a potentially effective modality for treating haematuria in patients with advanced prostate cancer.
Thurairaja
R
R
Department of Urology, Royal Devon and Exeter Hospital, Exeter, UK. rthurairaja@doctors.org.uk
Pocock
R
R
Crundwell
M
M
Stott
M
M
Rowlands
C
C
Srinivasan
R
R
Sheehan
D
D
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy; D006470:Hemorrhage / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000532:radiotherapy*; D011859:Radiography